Goldman Sachs Urges Shift to Defensive Stocks Amid AI Slowdown
Goldman Sachs advises investors to move into health care and consumer staples as rising capital costs threaten the durability of AI infrastructure spending.
Goldman Sachs recommends that investors shift toward health care and consumer staples stocks to defend against a potential slowdown in the artificial intelligence trade. Analysts warn that rising interest rates and capital costs have caused the equity market to downgrade growth expectations, which is significant given that AI capital spending currently accounts for roughly half of S&P 500 earnings growth.
The bank notes that higher financing costs and energy prices could threaten the durability of AI infrastructure buildouts. Consequently, the firm suggests focusing on quality attributes in defensive industries that have recently lagged the broader market. Specifically, the bank highlights CVS Health and Tyson Foods for their high free cash flow yields.
Despite these defensive recommendations, the base case from the bank maintains that earnings growth will persist. Analysts anticipate a potential recovery in consumer-facing stocks by 2027, provided that energy prices and interest rates decline.